SCHEMBL5133820

SCHEMBL5133820

C=Cc1ccc(-c2nnc(-c3cccc4ccccc34)o2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.59
▸ KDM4E B2RXH2 7/20 0.59
▸ RAB9A P51151 7/20 0.59
▸ HSD17B10 Q99714 6/20 0.59
▸ ATM Q13315 2/20 0.59
▸ CYP1A2 P05177 1/20 0.59
▸ CYP2C19 P33261 1/20 0.59
▸ TDP1 Q9NUW8 3/20 0.53
▸ ALOX12 P18054 2/20 0.53
▸ L3MBTL1 Q9Y468 2/20 0.53
▸ ALOX15 P16050 6/20 0.50
▸ ATR Q13535 1/20 0.46
▸ BCHE P06276 1/20 0.46
▸ ACHE P22303 1/20 0.46
▸ TSHR P16473 7/20 0.44
▸ HPGD P15428 6/20 0.43
▸ NPC1 O15118 5/20 0.43
▸ MAPT P10636 5/20 0.43
▸ SMN1; SMN2 Q16637 5/20 0.43
▸ TP53 P04637 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19932454 0.83 RAB9A (0.67) ALDH1A1KDM4ERAB9AHSD17B10ATM
SCHEMBL29355388 0.83 RAB9A (0.66) ALDH1A1KDM4ERAB9AHSD17B10ATM
SCHEMBL4333750 0.83 RAB9A (0.66) ALDH1A1KDM4ERAB9AHSD17B10ATM
SCHEMBL14627489 0.83 ALOX12 (0.53) ALDH1A1KDM4ERAB9AHSD17B10ATM
SCHEMBL29408668 0.81 ALOX15 (0.69) ALDH1A1KDM4ERAB9AHSD17B10ATM
SCHEMBL186871 0.81 ALOX15 (0.69) ALDH1A1KDM4ERAB9AHSD17B10ATM
SCHEMBL12177603 0.81 RAB9A (0.63) ALDH1A1KDM4ERAB9AHSD17B10ATM
SCHEMBL7114121 0.81 RAB9A (0.67) ALDH1A1KDM4ERAB9AHSD17B10ATM
SCHEMBL18716483 0.80 RAB9A (0.63) ALDH1A1KDM4ERAB9AHSD17B10ATM
SCHEMBL1720737 0.80 HSD17B10 (0.70) ALDH1A1KDM4ERAB9AHSD17B10ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6872474-B2 Light emitting polymer composition, and organic electroluminescence device and production process thereof JSR CORPORATION (JP) 2005-03-29 — — US claimed
US-6451458-B1 ALTERNATE COPOLYMER OF A HOLE TRANSFER MONOMER AND AN ELECTRON TRANSFER MONOMER; HOLE TRANSFER MONOMER IS A CARBAZOLE DERIVATIVE; ELECTRON TRANSFER MONOMER IS AN OXADIAZOLE DERIVATIVE JSR CORPORATION (JP) 2002-09-17 — — US claimed
US-9130183-B2 Organic electroluminescent element, displaying device and lighting device Konica Minolta, Inc. (JP) 2015-09-08 — — US disclosed
US-9130183-B2 Organic electroluminescent element, displaying device and lighting device Konica Minolta, Inc. (JP) 2015-09-08 — — US disclosed
US-8758903-B2 Organic electroluminescent element, display device and lighting device KONICA MINOLTA HOLDINGS, INC. (JP) 2014-06-24 — — US disclosed
US-8758903-B2 Organic electroluminescent element, display device and lighting device KONICA MINOLTA HOLDINGS, INC. (JP) 2014-06-24 — — US disclosed
US-8513649-B2 Vinyl-based polymer with silicon or/and tin and organic light emission diode using the same CHEIL INDUSTRIES, INC. (KR) 2013-08-20 — — US disclosed
US-8513649-B2 Vinyl-based polymer with silicon or/and tin and organic light emission diode using the same CHEIL INDUSTRIES, INC. (KR) 2013-08-20 — — US disclosed
US-8405301-B2 Organic electroluminescence element, display device and lighting device KONICA MINOLTA HOLDINGS INC. (JP) 2013-03-26 — — US disclosed
US-8405301-B2 Organic electroluminescence element, display device and lighting device KONICA MINOLTA HOLDINGS INC. (JP) 2013-03-26 — — US disclosed
EP-1953843-B1 ORGANIC ELECTROLUMINESCENT DEVICE, DISPLAY AND ILLUMINATING DEVICE KONICA MINOLTA HOLDINGS INC (JP) 2012-12-05 — — EP disclosed
EP-1311138-A1 Light emitting polymer composition, and organic electroluminescene device and production process thereof JSR Corporation (JP) 2003-05-14 — — EP disclosed
US-20030075533-A1 Material for organic electroluminescent device and its manufacturing method DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2003-04-24 — — US disclosed
US-20030057826-A1 Nitrogen-containing heterocyclic compound DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2003-03-27 — — US disclosed
US-6451458-B1 ALTERNATE COPOLYMER OF A HOLE TRANSFER MONOMER AND AN ELECTRON TRANSFER MONOMER; HOLE TRANSFER MONOMER IS A CARBAZOLE DERIVATIVE; ELECTRON TRANSFER MONOMER IS AN OXADIAZOLE DERIVATIVE JSR CORPORATION (JP) 2002-09-17 — — US disclosed
US-6440588-B1 1,4-DIAZEPINE COMPOUND WITH ELECTRON ATTRACTIVE GROUP SELECTED FROM THE GROUP CONSISTING OF CYANO GROUP, AN ACYL GROUP, AND AN ALKOXY GROUP DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2002-08-27 — — US disclosed
US-20020091256-A1 Azepine compounds DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2002-07-11 — — US disclosed
US-6399226-B1 Material for organic electroluminescence device and method for producing the same DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2002-06-04 — — US disclosed
EP-1107331-A2 Material for organic electroluminescence device and process for producing the same Daicel Chemical Industries, Ltd. (JP) 2001-06-13 — — EP disclosed
EP-1043915-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND METHOD FOR PRODUCING THE SAME Daicel Chemical Industries, Ltd. (JP) 2000-10-11 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030057826-A1 Nitrogen-containing heterocyclic compound NOD1, CYC1, NAP1L1 ALDH1A1 1694/4885KDM4E 972/4885RAB9A 3455/4885
US-20020091256-A1 Azepine compounds AZI2, ARL1, APOL1 ALDH1A1 440/4885KDM4E 1359/4885RAB9A 980/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback